Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis

Clinical trial NCT04707703 · TERMINATED

Trial details

NCT number: NCT04707703
Sponsor: Jeffrey Jenks, MD, MPH
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2 Aspergillosis Invasive

Start date: 2021-03-16
Primary completion: 2021-10-25
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.